T. Rowe Price Mid-Cap Growth Portfolio ALNY Holdings History
T. Rowe Price Mid-Cap Growth Portfolio's Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, T. Rowe Price Equity Series, Inc. held 31,665.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $8.55 Mil. This investment constitutes 1.7% of their stock portfolio, and T. Rowe Price Equity Series, Inc. now holds 0.02% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Mid-Cap Growth Portfolio has made 6 purchases of ALNY, at an average price of $135.02, for a total of 39,100.00 shares. In addition, there have been 4 sales at an average price of $183.85 for 7,435.00 shares. Based on historical transaction data and ALNY's current price of $322.67, T. Rowe Price Mid-Cap Growth Portfolio's estimated gain on his ALNY holdings is $6.30 Mil, reflecting a 119.42% gain to date.
T. Rowe Price Mid-Cap Growth Portfolio ALNY ($322.67) Holding Chart
T. Rowe Price Mid-Cap Growth Portfolio ALNY ($322.67) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
